Aspergillosis and Mucormycosis‐Associated Hospitalizations, United States, 2016–2021
Rates of A-RHs and M-RHs in the United States peaked in 2021, likely reflecting the increased burden of COVID-19 in 2021 compared with 2020. Ongoing monitoring of risk factors and clinician awareness is essential for managing and preventing these infections.
Authors
- Johnathan A. Edwards (ORCID: https://orcid.org/0000-0003-1292-7885)
- Kaitlin Benedict (ORCID: https://orcid.org/0000-0003-0458-2493)
- Jeremy A.W. Gold (ORCID: https://orcid.org/0000-0002-5054-7616)
- Robert J. Rhee
Institutions
- Centers for Disease Control and Prevention (US)
- Emory University (US)
- Stellenbosch University (ZA)
Publication Details
- Journal
- Mycoses
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1111/myc.70108
- Citations
- 1
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 1.40